Wound Care Advantage (WCA) Launches Advanced Discovery Research Alliance to Revolutionize Patient Care Through Evidence-Based...
April 24 2018 - 8:16PM
Business Wire
WCA, in partnership with Dr. David G.
Armstrong and the Southwestern Academic Limb Salvage Alliance
(SALSA), brings together an international network of advanced wound
centers for investigative research
Wound Care Advantage (WCA), in collaboration with
internationally renowned podiatric surgeon Dr. David G. Armstrong,
the Southwestern Academic Limb Salvage Alliance (SALSA) and Gen1
Research, has launched Advanced Discovery, a new investigative
research alliance dedicated to revolutionizing patient care through
evidence-based science. Advanced Discovery will offer access
to an international network of advanced wound and hyperbaric
treatment centers, laying the groundwork for meaningful
investigative research. In partnership with approved manufacturers
and research facilitators, the Alliance will evaluate a variety of
diagnostic and treatment modalities with a unified goal of
positively impacting wound healing outcomes while reducing the cost
of treatment. Gen1 will provide extensive administrative support
and infrastructure for the studies.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20180424006719/en/
Chronic wounds affect approximately 5.7 million patients in the
U.S., costing the healthcare system more than $20 billion
annually.1 This burden is growing, due to a rapid increase in
diabetes and vascular disease, an aging population, and rising
healthcare costs. In fact, the cost of diabetic foot ulcers is
greater than that of the five most costly forms of cancer2 and
diabetic foot ulcer patients are twice as costly to U.S. Medicare
as those with diabetes alone.3
By combining WCA and SALSA resources, Advanced Discovery
offers wound care product manufacturers a competitive advantage by
providing access to extensive de-identified clinical data from a
stable pool of participants. Advanced Discovery will harness
electronic clinical data collected from more than 42,000 patients
and 880,000 wound assessments over the past 16 years; data will
also be provided by SALSA, which has affiliations with universities
and colleges around the world, including Keck School of Medicine at
USC, one of the busiest clinical units in the country with more
than 10,000 patient visits per annum.
SALSA is led by Dr. Armstrong, who brings vast experience and
knowledge of wound care-specific research to the table. With an
intense focus on the diabetic foot, wound healing and amputation
prevention, Dr. Armstrong has produced more than 470 peer-reviewed
research papers in dozens of scholarly medical journals.
“By collaborating with Dr. Armstrong and partnering with one of
the world’s leading research teams, Advanced Discovery is
poised to make a significant impact on the wound care industry,”
said Mike Comer, CEO of Wound Care Advantage. “We’re committed to
facilitating safe and ethical research, and always focusing on
what’s best for the patient. As we celebrate our 16th year, we look
forward to the next 16 as we intensify our efforts on
revolutionizing wound treatment and giving a better quality of life
to our patients.”
“In the past, access to clinical studies and next-generation
research was only available to a select few,” said Dr. Armstrong.
“We’re upending that system and, in doing so, we can heal more
patients and help them live better lives.”
For more information about Advanced Discovery, please
call Wound Care Advantage at 888-484-3922 or visit
www.thewca.com.
About David G. Armstrong, DPM, MD, PhD
Dr. Armstrong is Professor of Surgery and Director of the
Southwestern Academic Limb Salvage Alliance (SALSA) at Keck School
of Medicine of University of Southern California (USC). He holds a
Master of Science in Tissue Repair and Wound Healing from the
University of Wales College of Medicine and a PhD from the
University of Manchester College of Medicine, where he was
appointed Visiting Professor of Medicine. He is founder and
co-Director of the Southwestern Academic Limb Salvage Alliance
(SALSA). Dr. Armstrong is co-Editor of the American Diabetes
Association’s (ADA) Clinical Care of the Diabetic Foot, now in its
third edition.
About Wound Care Advantage
Founded in 2002 and headquartered in Sierra Madre, California,
Wound Care Advantage is a leading provider and manager of
outpatient wound care and hyperbaric treatment centers. WCA forms
collaborative partnerships with hospitals and medical centers
across the country to help them build and manage patient-centered
wound care treatment programs. For more information,
visit http://www.thewca.com.
About Gen1 Research
Gen1 provides partner organizations with everything needed to
execute research, from highly qualified on-site coordinators to
proprietary data analytics & research management software.
Their experience and data-driven approach facilitates accurate
forecasting and delivery of on-time, credible results. For more
information, visit www.gen1research.com.
1 https://emedicine.medscape.com/article/1298452-overview2
https://diabeticfootonline.com/2013/10/11/new-data-diabetic-foot-complications-cost-of-5-most-costly-cancers-in-the-usa/3
https://diabeticfootonline.com/2013/11/05/burden-of-diabetic-foot-ulcers-for-medicare-and-private-insurers/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180424006719/en/
Wound Care AdvantageNorma VelvikisDirector of Corporate
Communicationsnvelvikis@thewca.com888-484-3922 x215